Table 1 Showed the results of quality assessment based on AHRQ* quality standards applied to included studies
From: Magnitude of diabetic peripheral neuropathy in Saudi Arabia: a systematic review and meta-analysis
Study Identification | Define source of information | List inclusion and exclusion criteria | Indicate time period used for identifying patients | Indicate whether participants were consecutive if not population-based | Indicate if evaluators of subjective components of the study were masked to other aspects of the status of the participants | Describe Assessment undertaken for quality assurance purposes | Explain any patient exclusions from analysis | Describe how confounding was assessed or controlled | Explain how missing data were handled in the analysis | Total |
|---|---|---|---|---|---|---|---|---|---|---|
Nielsen et al. [31] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 8 |
Akbar et al. [32] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 7 |
Mojaddidi et al. [40] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 7 |
Halawa et al. [8] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 8 |
Ahmed et al. [33] | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 6 |
Wang et al. [34] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 9 |
Kasim et al. [35] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 8 |
Shesha et al. [36] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 7 |
Shesha et al. [36] | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 7 |
Algeffari et al. [24] | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 6 |
Aljehani et al. [37] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 7 |
Sendi at al. [38] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 8 |
Almohaysen et al. [39] | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 7 |